Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, volgoat, for your thoughtful response -- and thanks to all others who responded as well.
Both volgoat and swg_tdr are much better at TA and charts than I'll ever be, and I post the following picture for their perusal. From what I see, the chart indicates a serious breakdown from a nearly year long symmetrical triangle (which we hopeaholics pray is a false breakdown); it also indicates that two of my favorite indicators have a positive divergence. On the other hand, there's been a bearish crossover of the 13/50 MA (which history shows is to be avoided!).
At any rate, price must get back within that triangle or else...VERY bad:
http://tinyurl.com/nhcm92r
volgoat, you've been around for at least as long as I have. I skip over most posters these days, but I always read your comments. I address this post to you for 2 reasons: (a)you are excellent at TA and you have a firm grasp of the science behind BAVI and (b)you seem upbeat even after yesterday's kick in the tush (per your post to Dr. Rocker that things are "heating up").
At this point, I really don't know what to think about this company. I've always been convinced about the science, but have had nothing but disdain for management. But it really makes no difference whether this investment fails (after almost 14 years)because of either science or management. The following historical items keep coming back to me and I cannot shake their negative effect:
(1) This company has a history of false starts. We get good news which rallies the stock one day, only to find that there is some informational tidbit which catastrophically collapses the share price shortly after. Look at a weekly chart. Since 2000 the share price has been on a steady decline with periodic spikes (2000, 2001, 2003, 2006, 2009, 2012). Except for 2012, every spike has registered a lower high than the previous spike.
Again, on a weekly chart, since 2003 every major low has been a lower low than the previous one.
(2) It was reported that the breast cancer trial had CRs (and as I recall, these people were suffering from advanced stages of the disease). Yet, next to nothing about it (that I can remember) in health or biotech news. Isn't that odd?
(3) IF our scientific data are so convincing, I cannot believe that one of the major drug companies would not have partnered with us -- on our terms. I know many have speculated here that management simply will not settle for the peanut price being offered by BP. But that's only speculation on our part (like
almost every thing else about this company). BUT if we truly have all the patents to PS immunotherapy locked up, I wouldn't think that any BP would risk letting PPHM go to someone else. It just doesn't make sense.
(4)Someone always seems to know ahead of time when bad news (or even news which could be seen as negative such as yesterday)is about to released and shorts the hell out of the stock. This gives me a very uneasy sense that big $ is consistently being made off the backs of the retail investors from info being provided by company insiders. It does nothing to form a perception of an honest company and its leadership.
(5) Things being done to the retail investors that seem to intentionally harm us: the pre-market release of the dosing disaster last September being the most egregious (and yesterday's pre-market release of a disastrously written communication being another).
When I step back from all of this, it is difficult to avoid the perception that something is seriously wrong.
Would you, in your generosity, explain why you remain optimistic? In fact, anyone who reads this post, I would very much like to read a summary of why you remain optimistic (if you do).
Perhaps this is the time for a sober, calm, objective reflection by the most knowledgeable IHUB Board minds of why investors should remain optimistic.
TIA.
Sean
P.S. Fred, I cannot respond to private emails. Thank you for returning to the Board. If you see this, I'd very much enjoy your reflection as well.
Ima....around $1.30 = pivot support #1.
co3aii
I can tell you WHAT the resistance is on the daily chart. I just cannot tell you why. BUT: third attempt may be the charm:
http://tinyurl.com/k3dtu8p
It's good to see you posting, swg_tdr. Thank you for your private reply yesterday; sadness.
swg_tdr....good to see you. Know of my continued prayers for the situation you relayed to me. I know how important Bavi is to you. (Sorry I'm unable to post private messages.)
Sean
Thanks for the initiative, Wook, and sharing with us the results.
Some do not think that charts mean much on small cap biotech like PPHM. I've found that perusing such information braces me for possible bad news (hopefully short term). So I offer the following for those who might be interested (especially since we're expecting a good size move due to the tight Bollinger Bands which lie within the Keltner Channel).
The "good news" is that short term charts are oversold.
http://tinyurl.com/bg9axdk
The "bad news" above is that indicators have deteriorated and unless the 200 SMA holds on the 60 minute chart, we're likely to see the $1.20s again.
More long term on the Weekly chart: http://tinyurl.com/aaq6usy
(1) There is still room to the downside within the RSI and UO Bollingers
(2)The 10 SMA has crossed under the the 20 SMA which one can see has not usually boded well for PPHM price.
(3) I noticed that the Weekly SAR is $1.22
On the Daily chart, everything is moving in the wrong direction:
http://tinyurl.com/bhgcjv5
Good news can change everything, but if there's a general market sell-off coming, it may be the catalyst for a bit of a tumble here.
Major move setting up: Bollinger Bands tight and well within the Keltner Channel. Usually indicates a pending big move.
Last time in February: went from c. $2.25 to c. $1.18
Time before that (January): went from c. $1.30 to c. $2.75
Volgoat, thank you both for your efforts to discover what you have and also sharing it with us.
By hook or by CROOK (probably naked shorting), the shorts want $1.15.
Thanks, Wook -- VERY much.
As CP has pointed out yesterdays attempted bear raid was unsuccessful, but one can almost palpably sense the bears sniffing around to test last week's low of $1.59.
Not Bob, most sorry for your loss. There are few more painful in this world
There are other posters here who have family suffering the same. Just a shout out to Fred -- my thoughts and prayers continue with you.
I have never held PPHM management in high regard. They've almost become an afterthought at this point in my assessments of this company and BAVI. They have never considered retail anything more than an entity that must be tolerated until they get BP on board.
I agree with investors here much smarter than me that the apparent results tell us less than what meets the eye. Most of these pancreatic cancer patients were very sick to begin with and had already shown resistance to any further treatment (and among many the disease had progressed into the liver which I understand is what eventually causes patient death). They simply may not have had time for the immuno aspects of BAVI to develop. So, as per usual with PPHM, we are left with more questions than answers. This management does weary me.
All this being said, I expect a better buying opportunity when the gap at $1.65 is closed. I attach a monthly chart which illustrates two indicators that have consistently corrected at near these levels. The entire market is due for a correction and I don't think PPHM will be exempt when it occurs. All IMO -- and I stand willing to be corrected by those who are far more veteran at this game than me.
http://tinyurl.com/cqbndw6
P.S. I would like to hear from informed posters Cloaked Protector and RRdog about their take after reflecting on today's PR.
Perhaps our initial reaction is due to our assumptions as to the length of time we had not heard of MOS for the pancreatic trials.
Does this comment from the press release deserve a tempering of our disappointment?
"The trial included the enrollment of patients with advanced metastatic disease including significant liver involvement and poor performance status associated with rapid disease progression."
Thanks for the info, Fire Fox.
Great find, volgoat. Many thanks.
Thanks, sunstar -- that last response was particularly helpful.
cheynew, sunstar and investingdog: thanks for the NVI responses. But if the NVI were improving it would be moving closer to its 255 EMA. It's falling further away. This cannot be a positive.
Thank you for your patience if I'm missing something!
Thanks for the reply BTK.
I watched The Clay video. He speaks about declining volume during this consolidation as being a classic set-up for a nice run to the north. As far as I know, this is not the same as NVI.
Negative Volume Index (NVI)
Would any trader familiar with the use of this technical data comment on the consistent and unrelenting deterioration of this signal on the daily chart since the September PPHM debacle?
TIA.
If I'm not mistaken, the CNBS ticker highlights stocks that are experiencing pre-market, intraday, or post-market price volatility, heavier than normal volume or both.
Paul (not the pphntoolong Paul!), I just read your private message of January 3rd. I am so sorry to hear of your heartache. FWIW: my prayers and good thoughts go out to you.
Sean
Make it so, volgoat!
Picard out.
Paul, with ALL the possible indications for Bavi (not to mention the Avid operation) why would King & Co. Take $10 a share for a buyout? I've heard others mention a number like this, but I don't understand the thinking.
TIA.
Wow, r622, that brings back a lot of memories --and reminders as to why I had acquired 40,000 shares (only to be reverse split into oblivion). By the way, what ever happened to ms kso?
Apologies, isco, to you and the Board. I was looking at a dated chart.
FWIW: The bollingers on the 30 minute chart are very tight and probably indicate some kind of move coming. Anybody's guess which way. Seems like many are expecting news on Monday; the move may be a final shakeout. We are a fair distance from our support pivots -- the first one being A $1.60 (which may be the reason for beambe's references).
Then again......too obvious?
md1225 said: "As Ive stated before the CODING DISCREPANCIES were between which patient received which bavi dose 1mg or 3mg in a subset of patients..."
I don't doubt an ounce of your veracity. What puzzles me is if that was the only problem, why the statement on that fateful morning in September when management said that investors should not rely on their prior comments regarding their lung cancer results? If it was just a question of dosage -- and not of results -- why the crisis tone of that press release?
Also, if IR replied to someone on this Board that the reviewing process should be a matter of weeks and not months, what is holding up those results?
Just trying to understand.
TIA.
swg_tdr: just caught your private email. Thank you.
CP, I hope you're right.
However, do we know whether or not these posted job openings are new or simply filling recent vacancies? If the former: good. If the latter, I'd not necessarily consider it a good sign.
As I'm certain that the traders on this site have been watching, there's a beautiful Cup&Handle formation on a 3 month chart. If executed, the target is about $2.50.
golfho...you have far more patience than me. But God bless you for trying.
The Money Flow Index (MFI) has not budged with this sell-off. In other words, real buyers haven't gone anywhere.
PPHM Daily Pivot: $1.23
PPHM 200 SMA: $1.16
PPHM Gap Fill: $1.16
PPHM has plenty of technical room to close above $1.50.
I'd be pleased if we closed the gap @ $1.16 today.